New insights into what drives organ transplant rejection

September 6, 2018, Brigham and Women's Hospital
Credit: CC0 Public Domain

When it comes to transplant rejection, some organs are far trickier than others. Some transplantable organs, such as the liver, are readily accepted by the recipient's immune system, rarely triggering an immune response and rejection. But the skin is a very different matter: Skin grafts have a high rate of rejection for unknown reasons.

Investigators from Brigham and Women's Hospital set out to understand why, hoping to capitalize on new biological insights to not only explain why transplants provoke the immune system but also what treatments can be given to an organ prior to transplantation to decrease the likelihood of . Their findings, with implications for the future of face transplantation, are published in Nature Communications.

"Our work in the lab is driven by clinical observation," said co-senior author Leonardo V. Riella, MD, Ph.D., medical director of the Vascularized Composite Tissue Transplant Program at BWH. "Skin grafts have such a high rate of rejection compared to other organs. We wanted to find out why."

Using a mouse model of skin transplantation, the team identified a novel, specific subset of cells in donor transplanted organs that triggered rejection. Known as CD103+ dendritic cells, this cell type appeared to play a major role in rejection. In its absence, researchers observed fewer signs that the recipient's immune system had been triggered and found that the transplanted skin survived longer.

In addition, the team was able to mitigate rejection by treating organs prior to transplantation. When were incubated with an anti-inflammatory mycobacterial protein, the grafts survived longer after transplantation. This effect was mediated by March-1, an enzyme that can inhibit the maturation of CD103+ dendritic cells in donor grafts. In addition to these observations in mouse models, the team also tested the effect of adding the mycobacterial protein to human skin grafts, finding signs that this treatment may help prevent an immune reaction.

Pre-treating skin grafts or other organs prior to transplantation represents a new, complementary strategy for preventing . "Today, most treatment focuses on the recipient side, using immunosuppressive drugs to try to prevent rejection," said Riella. "What we propose is a complementary strategy to tame the rejection process through direct treatment of the donor organ prior to transplantation. This could offer many benefits since we're focusing on an arm of the immune system—innate immunity—that immune suppressors cannot regulate."

The researchers plan to continue testing safety and effectiveness of this strategy in preclinical models and, if successful, will conduct phase 1 clinical trial in humans in the years ahead.

Explore further: Discovery could provide new prevention, treatment option for organ transplant rejection

More information: Thiago J. Borges et al, March1-dependent modulation of donor MHC II on CD103+ dendritic cells mitigates alloimmunity, Nature Communications (2018). DOI: 10.1038/s41467-018-05572-z

Related Stories

Discovery could provide new prevention, treatment option for organ transplant rejection

August 24, 2016
An international team led by researchers from the University of Pittsburgh School of Medicine found that targeting certain donor cells lowered the risk of organ rejection in mice that underwent kidney and heart transplants. ...

Whether the donor and recipient are male or female influences transplant rejection rates—investigators explore why

March 22, 2018
Biological sex differences can have far-reaching, clinical consequences, as illustrated by organ transplant outcomes. Men and women who receive donated organs can have different rates of transplant rejection, in some cases ...

Transplant medication matters for controlling cancer risk

August 1, 2018
Research reveals organ transplant recipients could reduce their risk of developing secondary skin cancer by changing their immunosuppressant medication.

Antibodies may predict transplant rejection risk

June 19, 2018
The presence of certain antibodies in patients may suggest a higher risk of transplant rejection across multiple organ types, including the kidney, liver, heart and lungs, according to a new study published in PLOS Medicine.

Clinical trial does not support the use of bortezomib for kidney transplant recipients

December 14, 2017
A new clinical trial looks at the potential of a new treatment for transplant rejection. The findings, which appear in an upcoming issue of the Journal of the American Society of Nephrology (JASN), do not support the use ...

Microbiota affect the rate of transplant acceptance and rejection

June 20, 2016
Researchers from the University of Chicago have shown that microbiota—the bacteria, viruses and other microbes living on the skin and in the digestive system—play an important role in the body's ability to accept transplanted ...

Recommended for you

3-D-printed tracheal splints used in groundbreaking pediatric surgery

September 19, 2018
Children's Healthcare of Atlanta has performed Georgia's first-ever procedure to place 3-D-printed tracheal splints in a pediatric patient. A cross-functional team of Children's surgeons used three custom-made splints, which ...

Muscle relaxants increase risk of respiratory complications

September 18, 2018
Muscle relaxants are a necessary part of anesthesia during certain major operations. However, studies have hinted at respiratory risks connected with these drugs. POPULAR, a major prospective observational European study ...

Gunshot victims require much more blood and are more likely to die than other trauma patients

September 17, 2018
In a new analysis of data submitted to Maryland's state trauma registry from 2005 to 2017, Johns Hopkins Medicine researchers found that gunshot victims are approximately five times more likely to require blood transfusions, ...

Liver allocation system disadvantages children awaiting transplants

September 17, 2018
Children are at a considerable disadvantage when competing with adults for livers from deceased organ donors in the U.S. allocation system, a University of Pittsburgh Graduate School of Public Health-led analysis reveals ...

Taste preferences connected to success of long-term weight loss after bariatric surgery

September 16, 2018
Following Roux-en-Y gastric bypass (RYGB), a type of bariatric surgery, many patients exhibit a reduction in taste preference for sweet and fatty foods, although this effect may only be temporary, according to new research ...

New insights into what drives organ transplant rejection

September 6, 2018
When it comes to transplant rejection, some organs are far trickier than others. Some transplantable organs, such as the liver, are readily accepted by the recipient's immune system, rarely triggering an immune response and ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.